Drug Shortage Report for CEFAZOLIN FOR INJECTION
Report ID | 183209 |
Drug Identification Number | 02437112 |
Brand name | CEFAZOLIN FOR INJECTION |
Common or Proper name | CEFAZOLIN FOR INJECTION |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | CEFAZOLIN |
Strength(s) | 1G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 25 VIALS |
ATC code | J01DB |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2023-02-03 |
Actual start date | |
Estimated end date | 2023-03-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-03-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-03-29 | French | Compare |
v4 | 2023-03-29 | English | Compare |
v3 | 2023-02-04 | English | Compare |
v2 | 2023-02-02 | French | Compare |
v1 | 2023-02-02 | English | Compare |
Showing 1 to 5 of 5